Inno Gene SA engages in the management of startup biotechnology companies. It also produces and distributes diagnostic products. The company was founded by Michal Kaszuba and Jacek Wojciechowicz in June 2010 and is headquartered in Poznan, Poland.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of IGN is 3.64 PLN — it has decreased by −1.62% in the past 24 hours. Watch INNO-GENE stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NEWCONNECT exchange INNO-GENE stocks are traded under the ticker IGN.
IGN stock has risen by 0.55% compared to the previous week, the month change is a 30.00% rise, over the last year INNO-GENE has showed a 4.60% increase.
IGN reached its all-time high on Oct 9, 2020 with the price of 98.80 PLN, and its all-time low was 0.88 PLN and was reached on Feb 15, 2019. View more price dynamics on IGN chart. See other stocks reaching their highest and lowest prices.
IGN stock is 8.67% volatile and has beta coefficient of −2.17. Track INNO-GENE stock price on the chart and check out the list of the most volatile stocks — is INNO-GENE there?
Today INNO-GENE has the market capitalization of 122.23 M, it has increased by 440.10% over the last week.
Yes, you can track INNO-GENE financials in yearly and quarterly reports right on TradingView.
IGN net income for the last quarter is −424.00 K PLN, while the quarter before that showed −218.25 K PLN of net income which accounts for −94.27% change. Track more INNO-GENE financial stats to get the full picture.
No, IGN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 10, 2024, the company has 10.00 employees. See our rating of the largest employees — is INNO-GENE on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INNO-GENE EBITDA is −2.16 M PLN, and current EBITDA margin is −254.17%. See more stats in INNO-GENE financial statements.
Like other stocks, IGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INNO-GENE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INNO-GENE technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INNO-GENE stock shows the sell signal. See more of INNO-GENE technicals for a more comprehensive analysis. If you're still not sure, try looking for inspiration in our curated watchlists.